Pharma manufacturing floor with technician monitoring production.
Sakar Healthcare announced a significant financial performance for the January-March quarter of the 2025-26 fiscal year, reporting a 91 percent surge in net profit to Rs 11.02 crore. This marks a substantial increase from the previous year’s performance.
Revenue from operations also saw robust growth, climbing by 42 percent to Rs 71.09 crore during the same period. This indicates strong top-line expansion alongside improved profitability.
For the full fiscal year 2025-26, Sakar Healthcare’s net profit rose by 74 percent to Rs 30.48 crore. The company’s revenue for the entire fiscal year increased by 42 percent, reaching Rs 251.73 crore, underscoring a consistent upward trend in its financial trajectory.
About the Author
